Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01281657 · ClinicalTrials.gov registry record
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A clinical trial, sponsored by Novartis.
- Completed
- Registry status
- 64
- Enrollment target
NCT01281657 is a clinical trial that has completed, run by Novartis. The registered enrollment target is 64 participants.
The verdict
NCT01281657 has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
The purpose of this observational study is to collect long-term data on safety and effectiveness of fingolimod, particularly including clinical disease and patient outcome related parameters such as relapse and disability, in patients who have participated in prior trials within the fingolimod clinical development program. Furthermore, this study explores the incidence of selected safety related outcomes of fingolimod treatment during follow-up visits within the context of routine medical practice.
Interventions
- DRUG fingolimod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01281657
The ClinicalTrials.gov registry entry for NCT01281657 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fingolimod is the first listed.
NCT01281657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01281657 about?
NCT01281657 is a clinical study titled "Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program". The purpose of this observational study is to collect long-term data on safety and effectiveness of fingolimod, particularly including clinical disease and patient outcome related parameters such as relapse and disability, in patients who have participated in prior trials within the fingolimod clini...
What is the current status of trial NCT01281657?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2011-02. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01281657?
The interventions under investigation include: fingolimod (DRUG).
Who is sponsoring clinical trial NCT01281657?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.